A press release

Trevi Therapeutics Raises $50 Million Series C Financing Led by New Enterprise Associates

Company continuing the development of Nalbuphine® ER in chronic pruritus conditions New Haven, CT, July 20, 2017 – Trevi Therapeutics, […]